Course Provider
Australian registered charity founded in 2019 that successfully campaigned for the Therapeutic Goods Administration (TGA) to reschedule psilocybin and MDMA in 2023 — making Australia the first country to formally approve these substances for clinical use. MMA trains clinicians through its Certificate in Psychedelic-Assisted Therapies (CPAT) program, funds clinical trials, and has supplied medicines and training to 100+ patients under the TGA Authorised Prescriber scheme.
Mind Medicine Australia sits at the clinical and policy end of the psychedelic field rather than the retreat or wellness end. Its CPAT programme appears best suited to qualified health professionals who want structured, regulator-facing preparation for legally delivered psychedelic-assisted therapy in Australia, not curious laypeople or informal facilitators. The organisation has real lineage in the Australian legalisation story and has recruited recognised figures from psychiatry and psychotherapy, but it is also a strong advocate, so readers should see it as a mission-led training provider with an explicit change agenda rather than a neutral university-style faculty.
Best for registered clinicians and allied health professionals who want to work in regulated psychedelic-assisted therapy in Australia. It also has a lower-intensity fundamentals course for clinicians, trainees, and interested members of the public.
CPAT is aimed at healthcare and mental health professionals and other eligible practitioners, and the course is described as building on skills already acquired in the mental health field. MMA says the three main roles are prescriber, primary therapist, and secondary therapist. Application and interview requirements apply, and applicants must sign a Student Code of Conduct.
CPAT is accredited by the Australian Medical CPD Standard. MMA states CPAT is accredited for 113 hours of Educational Activity and 14 hours of Reviewing Performance for psychiatrists and other medical doctors, and for 127 hours of CPD for psychologists and other healthcare professionals. MMA also says the course has been peer-reviewed by independent panels of psychiatrists and psychologists, and can count towards CPD points through relevant professional colleges or associations. Its shorter Fundamentals course offers a certificate of completion and 15 CPD hours.
CPAT pricing on MMA’s site is an application fee of $250 non-refundable, plus a course fee of $10,950 paid by instalments or $9,950 upfront, GST inclusive. MMA also says financial assistance is available for those unable to afford the full fee. The shorter Fundamentals course is marketed as a 6-week online programme with a $500 AUD CPAT credit, making the effective fee about $99 if used as intended.
Learners receive a CPAT credential and training in the knowledge and skills to safely and effectively administer psychedelic-assisted therapies in clinical settings. MMA positions the course as preparing practitioners for prescribing, primary therapy, or secondary therapy roles within regulated multidisciplinary care, and says graduates may gain professional experience through the MMA clinic. The Fundamentals course yields a certificate of completion and 15 CPD hours.
Linked Courses
8
Active Listings
4
Primary Formats
Hybrid, Self-paced
Programs linked directly to this provider in the Blossom course dataset.
By Mind Medicine Australia
Browse courses focused on integration therapy, including clinician training in psychedelic harm reduction and integration. Listings in this skill area emphasize support for patients navigating psychedelic experiences in clinical and non-clinical settings.
Next cohort: Sep 1, 2026
By Mind Medicine Australia
Browse courses focused on ketamine medicine therapy, including training in ketamine-assisted psychotherapy and related clinical skills.
Next cohort: Sep 1, 2026
By Mind Medicine Australia
Courses tagged with preparation therapy focus on ketamine-assisted psychotherapy and psychedelic-assisted psychotherapy practice. The current catalog includes two offerings from one provider, with formats that combine didactic learning, consultation, supervision, and shadowing.
Next cohort: Sep 1, 2026
By Mind Medicine Australia
Integral Psychedelic Therapy Training is a 5-year training program focused on psychedelic therapy within psychotherapy and psychedelic-assisted therapy. It emphasizes core and advanced topics, with attention to depth, trauma-informed approaches, and culturally responsive care.
Next cohort: Dec 1, 2026
Source lists: 121 hours
Delivery: Online + SF Bay Area, United States
Includes medicine self-experience
By Mind Medicine Australia
Sage Integrative Health offers ketamine-assisted therapy for depression, anxiety, trauma, and other mental health concerns. The service is provided by trained ketamine therapists and tailored to the patient’s needs.
Source lists: 3 hours
Delivery: Berkeley, United States + Online
Includes medicine self-experience
By Mind Medicine Australia
Holistic psychiatry and medication management for adults seeking care for anxiety, depression, PTSD, and related concerns. Sage Integrative Health serves Berkeley and the San Francisco Bay Area.
By Mind Medicine Australia
The Fundamentals of Psychedelic-Assisted Therapy for Mental Health is a 4-part online training program designed to educate medical and mental health professionals, individuals with lived experience, and consumers on the science and clinical use of psychedelics.
Source lists: 15 hours
Delivery: Self-paced + Online
By Mind Medicine Australia
The course is based on the CIIS program, adapted for the Australian context, and with input from MAPS, USONA, and others. It teaches therapists the research, therapy setting, risks, and therapeutic models for working with psychedelics.
Source lists: Estimated 121 hours
Delivery: Online + Australia
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.